These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 16784991)
1. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas. Attis MG; Burchette JL; Selim MA; Pham T; Soler AP Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991 [TBL] [Abstract][Full Text] [Related]
2. p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma. Hilliard NJ; Krahl D; Sellheyer K J Cutan Pathol; 2009 Jul; 36(7):753-9. PubMed ID: 19519606 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical staining of CD10 in atypical fibroxanthomas. Hultgren TL; DiMaio DJ J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198 [TBL] [Abstract][Full Text] [Related]
4. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas. Radfar A; Stefanato CM; Ghosn S; Bhawan J Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082 [TBL] [Abstract][Full Text] [Related]
5. KBA.62: a useful marker for primary and metastatic melanomas. Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211 [TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence. Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807 [TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays. Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225 [TBL] [Abstract][Full Text] [Related]
8. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases. de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419 [TBL] [Abstract][Full Text] [Related]
9. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar. Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825 [TBL] [Abstract][Full Text] [Related]
19. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas. de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901 [TBL] [Abstract][Full Text] [Related]
20. E-cadherin and beta-catenin expression patterns in malignant melanoma assessed by image analysis. Pećina-Slaus N; Zigmund M; Kusec V; Martić TN; Cacić M; Slaus M J Cutan Pathol; 2007 Mar; 34(3):239-46. PubMed ID: 17302608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]